pragma.vision Technology observatory & strategic foresight

Verification register Bio, Health & Neuro

Readiness verdict

Lunit INSIGHT CXR / MMG

A dated reading of what is claimed, reported, and independently verified in the current evidence.

As of
2026-08-20
Revision
1
Method
v1.3.0

Current reading

Readiness band and full integer triple

AI-assisted assembly · derived results

Readiness band

Mature

Primary summary from verified readiness

Confidence
84% · stale
Computed at
2026-08-20T10:53:37.157733+00:00
Claimed
85

Public ambition and stated capability

Reported
84

Observed practitioner reporting

Verified
76

Independently supported evidence

Gap
+9

Claimed leads verified

Evidence strength Strong

Decision

What the current evidence supports

Human editorial judgment · 2026-08-20

Adopt with guardrails

Why
FDA-cleared (both MMG and CXR), CE-marked in 35+ countries, large training set, peer-reviewed comparative accuracy, independent BreastScreen Norway validation, and real-world deployment data make it the most mature of the three — guardrails needed only because false positives and autonomous-reader regulation remain live constraints.
Next
Scope a concurrent-read (not replacement) pilot integrating INSIGHT MMG/CXR into existing double-reading or triage workflow, with prospective tracking of recall and cancer-detection rates against current baseline.

Constraints

Blockers

No named blocker is present in the current public projection.

Evidence summary

Derived counts

AI-assisted assembly

Total
12
Tier 1
6
Tier 2
1
Tier 3
5
Supports
10
Contradicts
2
Context
0
Latest observed
2026-02-24

Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.

Publication record

Revisions

Initial public reading

  1. 2026-07-19 Reading moved from mature to mature.

Your opinion

Tell us anything.

What works, what doesn't, what's missing — especially about our watches, lenses, and the register itself. Anonymous is fine; leave an email if you'd like a reply.